{"id":5498,"date":"2020-04-23T07:48:08","date_gmt":"2020-04-23T12:48:08","guid":{"rendered":"https:\/\/ibio.org\/?p=5498"},"modified":"2020-04-23T07:48:19","modified_gmt":"2020-04-23T12:48:19","slug":"takeda-expands-patient-assistance-in-the-u-s-during-covid-19-crisis","status":"publish","type":"post","link":"https:\/\/ibio.org\/takeda-expands-patient-assistance-in-the-u-s-during-covid-19-crisis\/","title":{"rendered":"Takeda Expands Patient Assistance in the U.S. During COVID-19 Crisis"},"content":{"rendered":"<p>As the COVID-19 crisis continues to unfold, Takeda\u2019s Patient Assistance Response team is working around the<br \/>\nclock to help ensure that the people who need our medicines and treatments can continue to access them safely<br \/>\nand without interruption.<\/p>\n<p>Consistent with our commitment to prioritizing patients\u2019 needs, Takeda has enhanced its existing patient<br \/>\nassistance programs for U.S. patients who qualify and need extra help during this difficult time. Highlights<br \/>\ninclude:<\/p>\n<ul>\n<li>Implementing a new Job Loss Provision for Takeda\u2019s Help at Hand program and Takeda\u2019s Oncology Patient<br \/>\nSupport program to help eligible patients who have lost a job and are experiencing a financial hardship due<br \/>\nto the COVID-19 pandemic. Click <a href=\"https:\/\/www.takeda.com\/en-us\/corporate-responsibility\/patient-assistance\/\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a> for a listing of Takeda medicines available through the Takeda Help at<br \/>\nHand patient assistance and support program. Click <a href=\"https:\/\/www.takedaoncology1point.com\/patient\/home\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a> for Takeda\u2019s Oncology Patient Support Program.<\/li>\n<li>Enhancing free drug programs for eligible patients enrolled in Takeda\u2019s <a href=\"https:\/\/www.onepath.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">OnePath<\/a>, Entyvio Connect,<br \/>\n<a href=\"https:\/\/www.hematologysupport.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">Hematology Support Center<\/a>, and <a href=\"https:\/\/www.takedaoncology1point.com\/patient\/home\" target=\"_blank\" rel=\"noopener noreferrer\">Takeda\u2019s Oncology Patient Support<\/a> programs, who have experienced a loss<br \/>\nor gap in insurance coverage due to COVID-19;<\/li>\n<li>Extending the eligibility period for certain patients currently enrolled in Takeda\u2019s patient assistance<br \/>\nprograms to help reduce the time patients spend on securing medication approvals so they can focus on<br \/>\ntheir health and safety during the pandemic;<\/li>\n<li>Implementing virtual training that pairs specially-trained nurses with patients to teach proper self-<br \/>\nadministration of certain Takeda medicines from the safety of patients\u2019 own homes. For more information,\u00a0see contact information for Takeda\u2019s Patient Assistance Programs below.<\/li>\n<\/ul>\n<p>Takeda\u2019s Patient Services Team is here to help you through this difficult time. For more information, as well as<br \/>\nadditional eligibility requirements, please refer to the following programs:<br \/>\nFor Takeda Help At Hand Patient Assistance Program (PAP), please call 1-800-830-9159, between<br \/>\n8:00am \u2013 8:30pm ET, Monday through Friday<br \/>\nFor Entyvio Connect, please call 1-855-368-9846, between 8:00am \u20138:00pm ET, Monday through Friday<br \/>\nFor OnePath, please call 1-866-888-0660, between 8:30am \u2013 8pm ET, Monday through Friday<br \/>\nFor Hematology Support Center, please call 1-888-229-8379, between 8:30am \u2013 8pm ET, Monday<br \/>\nthrough Friday<br \/>\nFor Takeda Oncology Patient Support, please call 1-844-817-6468, option 2, between 8:00am-8:00pm<br \/>\nET, Monday-Friday<\/p>\n","protected":false},"excerpt":{"rendered":"<p>As the COVID-19 crisis continues to unfold, Takeda\u2019s Patient Assistance Response team is working around the clock to help ensure that the people who need our medicines and treatments can continue to access them safely and without interruption. Consistent with our commitment to prioritizing patients\u2019 needs, Takeda has enhanced its existing patient assistance programs for [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":5499,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[337,145],"tags":[413,338],"class_list":["post-5498","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-covid","category-community-news","tag-drug-assistance","tag-takeda"],"_links":{"self":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts\/5498","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/comments?post=5498"}],"version-history":[{"count":0,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts\/5498\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/media\/5499"}],"wp:attachment":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/media?parent=5498"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/categories?post=5498"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/tags?post=5498"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}